About this Research Topic
Frontiers in Clinical Diabetes and Healthcare is delighted to present the ‘2022 in Review’ series of article collections.
2022 in Review: Diabetes Therapies will publish high-quality scholarly review papers on key topics around the clinical and epidemiological aspects relating to diabetes therapies. It aims to highlight recent advances in the field, whilst emphasizing important directions and new possibilities for future inquiries. We anticipate the research presented will promote discussion in the scientific community that will translate to best practice applications in clinical, public health and policy settings.
The collection Reviews in 2022: Diabetes Therapies welcomes full-length, mini or systematic review papers around any aspect relating to diabetes therapies. Themes around our most impactful research articles of 2022 will be welcomed; these include, but are not limited to:
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience
New articles will be added to this collection as they are published.
2022 in Review: Diabetes Therapies will publish high-quality scholarly review papers on key topics around the clinical and epidemiological aspects relating to diabetes therapies. It aims to highlight recent advances in the field, whilst emphasizing important directions and new possibilities for future inquiries. We anticipate the research presented will promote discussion in the scientific community that will translate to best practice applications in clinical, public health and policy settings.
The collection Reviews in 2022: Diabetes Therapies welcomes full-length, mini or systematic review papers around any aspect relating to diabetes therapies. Themes around our most impactful research articles of 2022 will be welcomed; these include, but are not limited to:
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience
New articles will be added to this collection as they are published.
Keywords: Diabetes, Therapies
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
